Trial Profile
Effect of Ticagrelor versus Clopidogrel on survival of patients with Coronary Chronic Total Occlusions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2018
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Therapeutic Use
- 13 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association